Di Chen

6.0k total citations · 1 hit paper
96 papers, 4.4k citations indexed

About

Di Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Di Chen has authored 96 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 51 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Di Chen's work include Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (21 papers) and Ubiquitin and proteasome pathways (17 papers). Di Chen is often cited by papers focused on Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (21 papers) and Ubiquitin and proteasome pathways (17 papers). Di Chen collaborates with scholars based in China, United States and Hong Kong. Di Chen's co-authors include Q. Ping Dou, Kristin R. Landis‐Piwowar, Kenyon G. Daniel, Hai‐long Piao, Tian Xia, Huan Qi, Xiaolong Liu, Qiuzhi Cindy Cui, Chao Duan and Hongxu Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Neuron.

In The Last Decade

Di Chen

93 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The double-edged roles of ROS in cancer prevention and therapy

2021 452 citations Huan Qi, Xiaolong Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Di Chen China	35	2.9k	1.3k	775	378	369	96	4.4k
Pithi Chanvorachote Thailand	39	2.8k 0.9×	1.1k 0.8×	962 1.2×	353 0.9×	394 1.1×	233	5.3k
Ammad Ahmad Farooqı Pakistan	39	3.3k 1.1×	1.5k 1.1×	755 1.0×	207 0.5×	485 1.3×	227	5.4k
Yunfei Zhou China	29	2.3k 0.8×	1.1k 0.8×	1.1k 1.5×	307 0.8×	265 0.7×	64	4.0k
Julien Verrax Belgium	34	3.1k 1.0×	1.7k 1.3×	468 0.6×	369 1.0×	322 0.9×	53	5.0k
Daniela Trisciuoglio Italy	35	2.9k 1.0×	951 0.7×	1.1k 1.4×	355 0.9×	496 1.3×	88	4.4k
Hongmei Li China	35	2.6k 0.9×	937 0.7×	841 1.1×	272 0.7×	751 2.0×	165	4.7k
Ming‐Hsien Chien Taiwan	39	2.9k 1.0×	1.3k 1.0×	874 1.1×	212 0.6×	503 1.4×	142	4.5k
Jiang‐Jiang Qin China	42	3.9k 1.3×	1.6k 1.2×	1.8k 2.3×	394 1.0×	364 1.0×	175	5.8k
Carlotta Granchi Italy	32	2.3k 0.8×	1.4k 1.0×	630 0.8×	432 1.1×	268 0.7×	109	4.1k

Countries citing papers authored by Di Chen

Since Specialization

Citations

This map shows the geographic impact of Di Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Chen more than expected).

Fields of papers citing papers by Di Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Chen. The network helps show where Di Chen may publish in the future.

Co-authorship network of co-authors of Di Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Di Chen. A scholar is included among the top collaborators of Di Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Chen. Di Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Di, Hailong Dong, Xiaopeng Wu, et al.. (2025). Multi-omics approach reveals differences in aroma and metabolic characteristics of two types of jackfruits. Food Chemistry X. 29. 102806–102806. 1 indexed citations

Wu, Wenjing, Jianchao Wang, Xuefeng Wang, et al.. (2025). Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma. Molecular Oncology. 19(8). 2388–2411. 1 indexed citations

Chen, Di, et al.. (2024). Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy. Clinical and Translational Medicine. 14(9). e1802–e1802. 7 indexed citations

Chen, Di, Xinyu Gu, Lixia Xu, et al.. (2024). Writers, readers, and erasers RNA modifications and drug resistance in cancer. Molecular Cancer. 23(1). 178–178. 37 indexed citations

Chen, Di, Lixia Xu, Weitao Shen, et al.. (2024). Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. SHILAP Revista de lepidopterología. 3(5). e238–e238. 23 indexed citations

Chen, Di, et al.. (2023). Serendipitous discovery of Class I HDAC inhibitors from rational design of molecular glue degraders targeting HDAC. European Journal of Medicinal Chemistry. 263. 115926–115926. 3 indexed citations

Chen, Di, Qiaoqiao Li, Jianguo Li, et al.. (2023). Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma. Cancer Cell International. 23(1). 316–316. 6 indexed citations

Xia, Tian, Di Chen, Xiaolong Liu, et al.. (2022). Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex. Cell Death and Disease. 13(4). 17 indexed citations

Jiang, Xin, Yushuang Xu, Di Chen, et al.. (2022). A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome. SHILAP Revista de lepidopterología. 5 indexed citations

10.

Chen, Di, Yong‐Long Zhao, Yan Li, et al.. (2021). Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6. ACS Chemical Biology. 16(12). 2746–2751. 47 indexed citations

11.

Chen, Di, Mengmeng Wang, Yushuang Xu, et al.. (2021). A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients. International Journal of General Medicine. Volume 14. 6935–6950. 8 indexed citations

12.

Chen, Di, Zhen Ning, Huan Chen, et al.. (2019). An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases. Oncogene. 39(3). 587–602. 13 indexed citations

13.

Lu, Xinyuan, Di Chen, Jie Ding, et al.. (2018). Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma. Frontiers in Pharmacology. 8. 973–973. 25 indexed citations

14.

Li, Xiaowei, Mingzuo Jiang, Di Chen, et al.. (2018). miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. Journal of Experimental & Clinical Cancer Research. 37(1). 71–71. 43 indexed citations

15.

Lu, Tong, Yuanyong Wang, Di Chen, Jia Liu, & Wenjie Jiao. (2018). Potential clinical application of lncRNAs in non-small cell lung cancer. OncoTargets and Therapy. Volume 11. 8045–8052. 76 indexed citations

16.

Guo, Weijie, Zhixiang Hu, Yuchen Li, et al.. (2018). A LIN28B Tumor-Specific Transcript in Cancer. Cell Reports. 22(8). 2016–2025. 26 indexed citations

17.

Zhang, Jiwei, Zhe Li, Longzi Liu, et al.. (2017). Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway. Hepatology. 67(1). 171–187. 178 indexed citations

18.

Chen, Di, Qiuzhi Cindy Cui, Huanjie Yang, & Q. Ping Dou. (2006). Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.. Cancer Epidemiology and Prevention Biomarkers. 15. 17 indexed citations

19.

Landis‐Piwowar, Kristin R., Vesna Milacic, Di Chen, et al.. (2006). The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resistance Updates. 9(6). 263–273. 123 indexed citations

20.

Daniel, Kenyon G., et al.. (2005). Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Research. 7(6). R897–908. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact